CLL/SLL Resources

The Resources You May Need—All in One Place

Whether you’re considering your treatment options or are already on your treatment journey with IMBRUVICA® (ibrutinib), it’s good to know and understand the resources and support you’ll have available to you once prescribed. Here you’ll find information about patient support, real patient stories about their experience with IMBRUVICA®, a guide to help start the conversation with your doctor about IMBRUVICA®, and more.

 

Our way: real journeys with IMBRUVICA®

Real patients share stories about their diagnosis of CLL/SLL—and the difference IMBRUVICA® has made

Surround Yourself With Support

As you move through your treatment journey with IMBRUVICA®, always keep in touch with your healthcare team, and don’t hesitate to ask questions. Your doctors, nurses, and pharmacists all bring specific types of expertise to your care and are ready to answer questions and provide you with support and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) resources.

Stay motivated

You are not alone. Surround yourself with friends, family, and support groups in order to stay motivated. One-on-one peer support programs, such as the Lymphoma Research Foundation’s support network (www.lymphoma.org), match lymphoma survivors and caregivers with volunteers who have gone through similar experiences.

Your family and friends may want to support you, but might not know how. Make sure to tell them exactly how they can help. You might ask a friend or family member to:

  • Come with you to doctor appointments
  • Go grocery shopping for you or with you
  • Do something fun to help you stay positive
 

Have questions about IMBRUVICA®?

From cost and coverage options to By Your Side Ambassador support—we're here to help.*

Explore Support Options
Thinking about treatment with IMBRUVICA®?

Sign up today to receive the latest information and helpful resources.

Start the conversation

Get useful tips and questions to ask your doctor that may help you make the right treatment decisions together.

Stay informed

Knowledge is empowering—so try to learn all you can about your condition. The websites below are good places to find additional information on CLL/SLL, treatment options, support groups, and resources.

For more information on CLL/SLL:

For cancer support communities:

IMBRUVICA® By Your Side patient support program is not intended to provide medical advice, replace prescribed treatment plans, or provide treatment or case management services. Patients are advised to talk to their healthcare provider and treatment team about any medical decisions and concerns they may have. By Your Side Ambassadors are provided by Janssen Biotech, Inc. and Pharmacyclics LLC, an AbbVie Company, and do not work under the direction of your healthcare professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.

Pharmacyclics, an AbbVie Company, may collect your personal data through your online and offline interactions with us, including your contact, demographic, geolocation, and health-related data. We may also collect your online usage data automatically through cookies and similar technologies. We use this data for several purposes, such as to provide you with and improve our programs, services, and products, customize your experiences, and for research and analytics. We retain your personal data for as long as necessary to fulfill these purposes or to comply with our record retention obligations. We do not sell your personal data but may use and disclose your personal data with marketing and advertising partners to deliver you ads based on your interests inferred from your activity across other unaffiliated sites and services (“online targeted advertising”) and for website analytics. To opt out of the use or disclosure of your personal data for online targeted advertising or for website analytics, go to Your Privacy Choices on our website. For more information on the personal data categories we collect, the purposes for their collection, our disclosures to third parties, your data subject rights, and our data retention criteria, visit our Privacy Notice.

Through my submission of the program enrollment form, I consent to the collection, use, and disclosure of my personal health data, as described in the Privacy Notice above and in AbbVie’s Privacy Notice in the How We May Disclose Personal Data section. My consent is required to process sensitive personal data under certain privacy laws, and I have the right to withdraw my consent by visiting Your Privacy Choices on AbbVie’s website.

IMBRUVICA® (ibrutinib) is covered by U.S. Patents, which are listed in FDA's Orange Book (available at
https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm).